Generation Bio Co. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Generation Bio Co. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Generation Bio Co. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $176M, a 27.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $176M +$37.7M +27.3% Dec 31, 2023 10-K 2024-03-06
Q4 2022 $138M +$39M +39.4% Dec 31, 2022 10-K 2024-03-06
Q4 2021 $98.9M +$37.9M +62.2% Dec 31, 2021 10-K 2024-03-06
Q4 2020 $61M +$27.9M +84.1% Dec 31, 2020 10-K 2023-02-23
Q4 2019 $33.1M +$18.9M +132% Dec 31, 2019 10-K 2022-02-24
Q4 2018 $14.2M Dec 31, 2018 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.